THURSDAY, April 7, 2022 (HealthDay News) – COVID -19 increases people’s risk of severe bleeding and hemorrhage for months after illness, researchers say.
Recent evidence suggests that COVID-19 is an independent cause of deep vein thrombosis, pulmonary embolism and hemorrhage.
“Our knowledge supports that [treatment] prevent thrombotic events, especially for high-risk patients, and enhance the importance of COVID-19 binding, ”the researchers concluded in a report published April 6 in BMJ.
Although a significant increase in clots and bleeding was observed, the length of time was not clear, the researchers found in a news report.
To find out, the researchers estimated that more than one million people in Sweden tested positive for COVID-19 between Feb. 1, 2020, and May 25, 2021, and a control group of more than 4 million people did not have a good COVID report.
Compared with the control group, COVID-19 patients were more likely to have deep vein thrombosis, or DVT, (a blood clot in the leg) up to three months after diagnosis; pulmonary embolism (a blood clot in the lungs) for up to six months; and a blood test for two months.
After listing several key factors, the researchers concluded that people with COVID-19 had a five-fold higher risk of DVT; the risk of pulmonary embolism was 33; and blood pressure nearly doubled in the 30 days after infection.
Deep vein thrombosis was found in 0.04% of COVID-19 patients and 0.01% of venereal patients. Pulmonary embolism was found in 0.17% of COVID-19 patients and 0.004% of non-COVID patients. And blood tests were performed in 0.10% of COVID-19 patients and 0.04% of diabetic patients, according to the report.
Blood and blood pressure problems were higher in patients with more COVID-19, those with other health conditions and those with the first wave than those with the second and third waves. The researchers said it could be explained by the improved care and coverage of chronic diseases after the first wave.
Patients with COVID-19 disease had a higher risk of DVT and pulmonary embolism, the study found. Although high blood pressure is not detected in people with simple COVID, there is a significant increase in patients with more advanced disease.
The study was led by Anne-Marie Fors Connolly of the department of clinical microbiology at Umeå University in Sweden.
Frederick Ho of the Institute of Health and Wellbeing at the University of Glasgow in Scotland and his colleagues wrote a review that combined the findings.
While many countries are opening up the disease limits and changing their mind about living with COVID-19, “this study reminds us of the need to be vigilant about complaints related to disease. SARS-CoV-2, with thromboembolism, ”Ho’s team said. write.
More on COVID-19 and blood at the U.S. National Heart, Lung, and Blood Institute.
KUMU: BMJnews release, April 6, 2022